Since spinning out of MIT in 2022, AgZen has pioneered feedback optimization for agrochemical application, ensuring every droplet and granule is applied with precision to maximize efficiency and ...

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...

LH stays on investors' radar owing to its strong focus on high-growth areas and pursuing strategic acquisitions.

Foresight Diagnostics and the University of Washington School of Medicine and Fred Hutch Cancer Center have announced the ...

VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have ...

Researchers are testing whether the Clarity ctDNA test can reliably identify patients who do just as well long term with less chemotherapy.

More than 5 years after the American Society of Clinical Oncology warned of emerging disparities in precision medicine, ...

The global Liquid Biopsy Market is experiencing significant growth, driven by increasing cancer prevalence, advancements in ...

The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

Foresight Diagnostics Inc., a Boulder-based cancer diagnostics company that specialized in the development of ultra-sensitive minimal residual disease, or MRD, detection, recently expanded its ...

Class A shares of the Alger Small Cap Focus Fund outperformed the Russell 2000 Growth Index during the fourth quarter of 2024 ...

Patients who received cilta-cel had improvements in progression-free survival and overall survival if they had sustained a minimal residual disease-negative complete response or better for at least 1 ...